Clinical Characteristics and Outcome of MPOX Patients Admitted to the Bukavu University Clinics in the Democratic Republic of Congo From July to December 2024: Open Cohort Study

2024年7月至12月刚果民主共和国布卡武大学诊所收治的MPOX患者的临床特征和预后:开放队列研究

阅读:1

Abstract

Background: Several studies have focused on the town of Kamituga, the epicentre of the current MPOX Clade Ib epidemic, in South Kivu Province, in the east of the Democratic Republic of Congo. However, the disease is widespread in several health zones in this province. Objectives: The aim of this study was to describe the clinical characteristics and vital prognosis of admissions for MPOX in the city of Bukavu (21,808 inhabitants/km(2)), in the province of South Kivu. Methodology: Between 1 July and 31 December 2024, MPOX patients were recruited as and when they were admitted to the treatment centre at the Bukavu university clinics. For each patient, clinical characteristics and outcome were sought. Results: Of the 343 patients hospitalized during this study period, 201 (58.6%) were men and 142 (41.4%) were women (p=0.001). The median age was 21.0 (11.0-27.7) years. Traders (42.3%) and field workers (24.7%) were more numerous. Contact with an MPOX case (61.2%) was the most frequent mode of contamination. The frequency was 70.2% for elevated white blood cells, 73.0% for elevated c-reactive protein, 37.9% for anemia, 43.1% for genital lesions, 7.0% for pregnancy and 2.6% for HIV. Finally, during the 2400 patient-day observation period, 3 patients subsequently died (0.8%). The incidence of death was 1.25/1000 patient days. Conclusion: The results of this study show that, in the city of Bukavu, MPOX is a disease of young people. Contact with a case of MPOX was the most important mode of contamination, and the professions at risk were trade and field work. Thus, the list of professions at risk of MPOX to be vaccinated must be established according to each region.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。